ストックスクリーナーアプリを入手
4.88
3.37%
-0.17
アフターアワーズ：
4.88
Sophia Genetics Sa (SOPH) 最新ニュース
Undervalued Opportunities: Top Penny Stocks To Watch In May 2026 - Sahm
SOPHiA GENETICS (SOPH) president’s 761-share tax sale under 10b5-1 plan - Stock Titan
SOPHiA GENETICS (SOPH) CSO sells shares to cover RSU tax via 10b5-1 plan - Stock Titan
[Form 4] SOPHiA GENETICS SA Insider Trading Activity - Stock Titan
SOPHiA GENETICS (SOPH) CMO pre-planned sale of 608 shares for tax - Stock Titan
Tax-driven sale: SOPHiA GENETICS (SOPH) CLO disposes 684 shares - Stock Titan
SOPHiA GENETICS (SOPH) CPO sells 380 shares to cover RSU taxes - Stock Titan
SOPHiA GENETICS (SOPH) CSO sells 33 shares in tax sell-to-cover - Stock Titan
JURGI CAMBLONG sells shares under 10b5-1 (SOPH) - Stock Titan
Manuela Valente files Form 144 to sell SOPH shares (NASDAQ: SOPH) - Stock Titan
SOPH (NASDAQ) insider RSUs recorded; Philippe Menu reports multiple 10b5-1 sales - Stock Titan
761 RSUs filed; prior 10b5-1 sales by Ross J Muken (SOPH) - Stock Titan
Form 144: 684 RSUs flagged for sale by Morgan Stanley Smith Barney (SOPH) - Stock Titan
Rule 144: Officer/holder lists 4,608 RSUs for sale (SOPH) - Stock Titan
SOPHiA GENETICS Files Form 6-K and Publishes 2025 ESG Impact Summary - TipRanks
SOPHiA GENETICS (SOPH) publishes 2025 ESG Impact Summary for investors - Stock Titan
SOPHiA GENETICS (SOPH) CSO executes 4,000-share sale under 10b5-1 plan - Stock Titan
Insider Sell: Philippe Menu Sells 5,000 Shares of Sophia Genetics SA - GuruFocus
Director Kathy Hibbs sells SOPHiA GENETICS (SOPH) shares under 10b5-1 plan - Stock Titan
SOPHiA GENETICS (SOPH) CMO pre-planned sale of 5,000 shares - Stock Titan
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K. - marketscreener.com
New NHS blood test aims to speed lung and breast cancer treatment - Stock Titan
SOPHiA Genetics inks two deals to advance AI for precision medicine - MSN
SOPHiA GENETICS (SOPH) CEO 10b5-1 sale of 8,500 shares - Stock Titan
TradingKey - tradingkey.com
How SOPHiA (SOPH) performance reflects its true potential (-4.63%) 2026-05-08Macro Trends - Newser
SOPHiA GENETICS schedules annual general meeting for June 18 in Switzerland - Investing.com Nigeria
SOPHiA GENETICS schedules annual general meeting for June 18 in Switzerland By Investing.com - Investing.com South Africa
SOPHiA GENETICS Calls 2026 AGM as It Highlights Breakout 2025 Growth - TipRanks
Leadership change and pay votes at SOPHiA GENETICS (Nasdaq: SOPH) - Stock Titan
SOPHiA GENETICS SA 2026 Q1ResultsEarnings Call Presentation (NASDAQ:SOPH) 2026-05-07 - Seeking Alpha
SOPHiA GENETICS (NASDAQ:SOPH) Earns Buy Rating from BTIG Research - MarketBeat
SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q1 2026 Earnings Call Transcript - Insider Monkey
BTIG reiterates Sophia Genetics stock rating on strong Q1 growth - Investing.com UK
BTIG reiterates Sophia Genetics stock rating on strong Q1 growth By Investing.com - Investing.com Australia
SOPHiA GENETICS Earnings Call: Growth With Caveats - TipRanks
SOPHiA GENETICS S.A. Q1 2026 Earnings Call Summary - Yahoo Finance
SOPHiA GENETICS Q1 Earnings Call Highlights - MarketBeat
SOPHiA Genetics (SOPH) Q1 2026 Earnings Transcript - AOL.com
SOPHiA GENETICS (NASDAQ:SOPH) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS - MarketBeat
SOPH: Q1 revenue up 22%, record platform usage, and strong margin; 2026 guidance reaffirmed - TradingView
SOPHiA GENETICS SA reports results for the quarter ended March 31Earnings Summary - TradingView
BTIG Raises its Price Target on SOPHiA GENETICS (SOPH) to $8 - Insider Monkey
SOPHiA GENETICS Posts Higher Q1 2026 Revenue but Wider Loss in Newly Filed Form 6-K - TipRanks
SOPH: Q1 2026 revenue up 22% year-over-year, with improved margins and strong global expansion - TradingView
SOPHiA GENETICS Reports First Quarter 2026 Results - ChartMill
SOPHiA GENETICS (SOPH) grows Q1 2026 revenue 22% but remains loss-making - Stock Titan
How SOPHiA (SOPH) responds to market challenges (Technical Weakness) 2026-05-05Pre-Earnings Momentum - Newser
SOPHiA GENETICS SA expected to post a loss of 23 cents a shareEarnings Preview - TradingView
SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $24,100.00 in Stock - MarketBeat
SOPHiA GENETICS (SOPH) CMO sells 5,000 shares under 10b5-1 plan - Stock Titan
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Drops By 31.0% - MarketBeat
SOPHiA GENETICS (SOPH) Projected to Post Earnings on Tuesday - MarketBeat
SOPH Price Today: SOPHiA GENETICS SA Stock Price, Quote & Chart | MEXC - MEXC Exchange
How The SOPHiA GENETICS (NasdaqGS:SOPH) Narrative Is Shifting With New Fair Value Targets - Yahoo Finance
Tangible book value per share of SOPHiA GENETICS SA – LS:A3CVT8 - TradingView
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results (PR Newswire) - Aktiellt
SOPHiA (SOPH) Industry Outlook | SOPHiA GENETICS SA misses EPS by 3.2% on $77.3M revenueProfit - Cổng thông tin điện tử tỉnh Lào Cai
SOPH Insider Selling: 7 Officers Dispose Shares April 22, 2026 - Meyka
0.66%
4.05%
大文字化:
|
ボリューム (24 時間):